Motixafortide and Stem Cell Transplants for Multiple Myeloma - NCI

Product Description

Motixafortide mobilizes more stem cells in people with multiple myeloma, potentially expanding the use of stem cell transplants for these patients.

Treatment National Cancer Institute

Investigational drug may improve stem cell transplantation for

Autologous Transplantation Using Donor Leukocytes Loaded Ex Vivo

PDF) Peripheral Blood Stem Cell Transplants for Multiple Myeloma

Multiple Myeloma Treatments

Mutsa Takundwa, PhD (Pr.Sci.Nat) (she) on LinkedIn: Motixafortide

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor

Clinical updates in blood and marrow transplantation in multiple

Multiple Myeloma, Conditions

Pharmacological inhibition of EGFR signaling enhances G-CSF

Salvage treatment with plerixafor in poor mobilizing allogeneic

Machine learning–based scoring models to predict hematopoietic